News | October 28, 2024
Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr
Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024
Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024
Indoco is comprehensively working on the remedial action plan
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
Subscribe To Our Newsletter & Stay Updated
